NCT03274258
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Explore clinical trials studying Loss of INI 1 Protein Expression. Study availability and eligibility vary by location and protocol.
NCT03274258